Dexamethasone and monophosphoryl lipid a-modulated dendritic cells promote antigen-specific tolerogenic properties on naive and memory cd4+ t cells.
Frontiers in Immunology
dc.creator | Maggi, Jaxaira | |
dc.creator | Schinnerling, Katina | |
dc.creator | Pesce, Barbara | |
dc.creator | Hilkens, Catharien M | |
dc.creator | Catalán, Diego Francisco | |
dc.creator | Aguillón-Gutiérrez, Juan Carlos | |
dc.date | 2018-11-29T15:36:51Z | |
dc.date | 2022-07-07T15:55:28Z | |
dc.date | 2014 | |
dc.date | 2018-11-29T15:36:51Z | |
dc.date | 2022-07-07T15:55:28Z | |
dc.date | 2016 | |
dc.date.accessioned | 2023-08-22T22:32:51Z | |
dc.date.available | 2023-08-22T22:32:51Z | |
dc.identifier | 1140553 | |
dc.identifier | 1140553 | |
dc.identifier | https://hdl.handle.net/10533/228542 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8347396 | |
dc.description | Tolerogenic dendritic cells (DCs) are a promising tool to control T cell-mediated autoimmunity. Here, we evaluate the ability of dexamethasone-modulated and monophosphoryl lipid A (MPLA)-activated DCs [MPLA-tolerogenic DCs (tDCs)] to exert immunomodulato | |
dc.description | Regular | |
dc.description | FONDECYT | |
dc.description | FONDECYT | |
dc.language | eng | |
dc.relation | handle/10533/111556 | |
dc.relation | handle/10533/111541 | |
dc.relation | handle/10533/108045 | |
dc.relation | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027201/ | |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Chile | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Dexamethasone and monophosphoryl lipid a-modulated dendritic cells promote antigen-specific tolerogenic properties on naive and memory cd4+ t cells. | |
dc.title | Frontiers in Immunology | |
dc.type | Articulo | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion |